Allied Market Research


Poultry Vaccine Market

Poultry Vaccine Market Size, Share, Competitive Landscape and Trend Analysis Report, by Disease Type, by Product Type, by Dosage Form, by Application and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Poultry Vaccine is considered as most important part of health management of poultry. It is used to prevent a particular disease and help to boost the immunity of poultry to produce antibody that protect the poultry from infectious disease. Vaccine is an important component to control disease. There are various routes of administration for vaccinating the poultry such as nasal, oral, subcutaneous ocular, in-vivo intramuscular and others. While vaccinating the chicken, it is applied on different areas of egg such as body of embryo, allantois sac, yolk sac, amniotic fluid. Important thing that have to maintain during in-vivo vaccination such as maintain air filter, adjust weather condition, reduce air circulation, and maintain hatchery insulation. CVB Center for veterinary Biologic grant the permission to animal health companies to manufacture and sell veterinary biologics. The global poultry vaccine market is experiencing a significant growth, and will grow considerably in next few years. 


COVID-19 Scenario Analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs.Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Ongoing COVID -19 Pandemic is affecting the poultry vaccine market. It mostly affects the vaccine production industries, it decreases the demand and supply chain of the product as well as affects poultry sale and distribution, as because of growing infectious diseases, consumer is not ready to buy the poultry product, which decreases the poultry market growth.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

In 2017, the United States Department of Agriculture (USDA) reported that total 108.6 pounds of consumers consumed poultry products.  According to Merial Health, by 2020, chicken is expected to overtake pork as the animal protein of choice globally. Thus, the poultry industry plays a vital role in ensuring food for the future global population. As per National Chicken Council, in 2018, per capita consumption of poultry was 109.5 pound.

Globally, North America is the most dominating region in the market due to rising production of egg, rising consumer awareness about the food safety, rising consumption of poultry derived product, growing zoonotic diseases related with poultry, growing advancement in vaccine development such as development of live gene deleted vaccine, non- replicating recombinant antigen vaccine, live vector vaccine, and nucleic acid mediated vaccines. Whereas, Europe is considered as the second largest market for poultry vaccine in the world. Asia-Pacific is expected to increase growth rate of the poultry vaccine market due to increasing veterinary healthcare expenditure, rising government vaccination program, growing poultry production and India is considered as the second fastest growing market for processed meat. 

The driving factors are - increasing vaccine innovation, cost-effective animal health expenditure, rising demand for poultry vaccination, poultry derived food product, rising technological advancement, increasing prevalence of zoonotic disease, increasing poultry population, rising government initiative in poultry treatment, and increasing vaccination program by leading industries. The factor that restrain the market growth of poultry vaccine are - increasing cost of vaccine, increasing acceptance of vegetarian food, decreasing production of advanced vaccine and increasing investment in animal health. 

New product launches to flourish the market

The launch of new product that contain improved capabilities have been launched by leading market player. They have taken necessary steps to improve accuracy of devices and overall functionality as well. MSD Animal Health used biotechnology to launch the world first dual construct Herpes Virus of Turkeys (HVT) vaccine that simultaneously protects the birds from infectious Bursal, Newcastle and Mareck’s disease. Merial the animal health division of Sanofi launched the new product such as, The AvinewTM Neo Effervescent tablet vaccine, which helps to treat the Newcastle Disease Virus (NDV). “Merial Avinew Vaccine” is the world number one vaccine.    

Key benefits of the report:

  • This study presents the analytical depiction of the global poultry vaccine market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global thermistor market share.
  • The current market is quantitatively analyzed to highlight the global poultry vaccine market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global poultry vaccine market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the poultry vaccine market research report:

  • What are the leading market players active in the poultry vaccine market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the poultry vaccine market?
  • What are the projections for the future that would help in taking further strategic steps?

Poultry Vaccine Market Report Highlights

Aspects Details
By Disease Type
  • Avian Influenza
  • Infectious Bronchitis
By Product Type
  • Recombinant Vaccine
  • Live Attenuated Vaccine
  • Inactivated Vaccine
  • Others
By Dosage Form
  • Liquid Vaccine
  • Freeze Dried Vaccine
By Application
  • Breeder
  • Broiler
By End User
  • Veterinary Hospitals
  • Poultry Firm
  • Poultry Vaccination Center
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Bio-vet,, Hester Biosciences Limited,, Merck & co.,, Ceva Animal Health,, Venkys,, Ringpu Biology,, Anicon GmbH, Phibro Animal Health Corporation, Borhringer Ingelheim,, Biovac, Zoetis Inc.,

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Poultry Vaccine Market

Global Opportunity Analysis and Industry Forecast, 2023-2032